Lastacaft

Active Ingredient(s): Alcaftadine
FDA Approved: * July 28, 2010
Pharm Company: * VISTAKON PHARMA
Category: Vision / Eye Health

Alcaftadine is used to prevent eye irritation brought on by allergic conjunctivitis. It is a H1 histamine receptor antagonist.[2] It was approved by the U.S. Food and Drug Administration (FDA) in July 2010, under the trade name Lastacaft.[3] Contents 1 Pharmacology 2 Clinical relevance 3 Adverse effects 4 Pharmacokinetics 5 Sales 6 See also 7 References 8 External links Pharmacology Alcaftadine is an antagonist at three of the histamine receptors (1, 2 a... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Lastacaft 2.5 mg/ml Ophthalmic Solution/ Drops
NDC: 0023-4290
Labeler:
Allergan, Inc.
Lastacaft 2.5 mg/ml Ophthalmic Solution/ Drops
NDC: 0023-4291
Labeler:
Allergan, Inc.
Lastacaft 2.5 mg/ml Ophthalmic Solution/ Drops
NDC: 42254-288
Labeler:
Rebel Distributors Corp
Lastacaft 2.5 mg/ml Ophthalmic Solution/ Drops
NDC: 54868-6294
Labeler:
Physicians Total Care, Inc.